Friday, March 18, 2022 1:37:55 PM
11:02 am ET March 18, 2022
New York Yankees and Duke Basketball
Recent BBLG News
- Bone Biologics Announces Closing of $2.0 Million Public Offering • Business Wire • 03/06/2024 09:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2024 05:15:24 AM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 03/04/2024 10:21:24 PM
- Bone Biologics Announces Pricing of $2.0 Million Public Offering • Business Wire • 03/04/2024 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:05:30 PM
- Bone Biologics Reports Progress With NB1 Clinical Program • Business Wire • 03/01/2024 01:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/26/2024 09:50:51 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/23/2024 10:09:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/21/2024 10:05:59 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 11:41:42 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:55:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:03:32 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2024 10:09:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 10:24:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 10:22:54 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/17/2024 10:21:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 10:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 01:15:18 PM
- Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors • Business Wire • 01/11/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:17:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 01:15:12 PM
- Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements • Business Wire • 01/10/2024 01:00:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/05/2024 10:15:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM